NCT00749749 - Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 10, 2008

Primary Completion Date

December 22, 2008

Study Completion Date

December 22, 2008

Conditions

Pain, Postoperative

Interventions

DRUG

Bupivacaine Collagen Sponge (CollaRx Bupivacaine Implant)

The bupivacaine collagen sponge contains 70mg Type I bovine collagen and 50mg bupivacaine hydrochloride

DRUG

ON-Q PainBuster Post-op Pain relief System

5 mL/hr per catheter of 0.25% bupivacaine (12.5 mg) for 72 hours(total dose 360 mL \[900 mg\])

Trial Locations (1)

Visions Clinical Research, Boynton Beach